DE69215316D1 - Zusammensetzungen, die Tramadol und irgendein Kodein, Oxykoden oder Hydrokoden enthalten, und deren Verwendung - Google Patents
Zusammensetzungen, die Tramadol und irgendein Kodein, Oxykoden oder Hydrokoden enthalten, und deren VerwendungInfo
- Publication number
- DE69215316D1 DE69215316D1 DE69215316T DE69215316T DE69215316D1 DE 69215316 D1 DE69215316 D1 DE 69215316D1 DE 69215316 T DE69215316 T DE 69215316T DE 69215316 T DE69215316 T DE 69215316T DE 69215316 D1 DE69215316 D1 DE 69215316D1
- Authority
- DE
- Germany
- Prior art keywords
- compositions
- codeine
- oxycode
- hydrocode
- compositions containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000203 mixture Substances 0.000 title abstract 7
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 title abstract 6
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 title abstract 5
- TVYLLZQTGLZFBW-ZBFHGGJFSA-N (R,R)-tramadol Chemical compound COC1=CC=CC([C@]2(O)[C@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-ZBFHGGJFSA-N 0.000 title abstract 3
- 229960004126 codeine Drugs 0.000 title abstract 3
- 229960004380 tramadol Drugs 0.000 title abstract 3
- TVYLLZQTGLZFBW-GOEBONIOSA-N tramadol Natural products COC1=CC=CC([C@@]2(O)[C@@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-GOEBONIOSA-N 0.000 title abstract 3
- BRUQQQPBMZOVGD-XFKAJCMBSA-N Oxycodone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(OC)C2=C5[C@@]13CCN4C BRUQQQPBMZOVGD-XFKAJCMBSA-N 0.000 abstract 2
- XYYVYLMBEZUESM-UHFFFAOYSA-N dihydrocodeine Natural products C1C(N(CCC234)C)C2C=CC(=O)C3OC2=C4C1=CC=C2OC XYYVYLMBEZUESM-UHFFFAOYSA-N 0.000 abstract 2
- LLPOLZWFYMWNKH-CMKMFDCUSA-N hydrocodone Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)CC(=O)[C@@H]1OC1=C2C3=CC=C1OC LLPOLZWFYMWNKH-CMKMFDCUSA-N 0.000 abstract 2
- 229960000240 hydrocodone Drugs 0.000 abstract 2
- 239000000463 material Substances 0.000 abstract 2
- 229960002085 oxycodone Drugs 0.000 abstract 2
- LLPOLZWFYMWNKH-UHFFFAOYSA-N trans-dihydrocodeinone Natural products C1C(N(CCC234)C)C2CCC(=O)C3OC2=C4C1=CC=C2OC LLPOLZWFYMWNKH-UHFFFAOYSA-N 0.000 abstract 2
- 206010010774 Constipation Diseases 0.000 abstract 1
- 206010012735 Diarrhoea Diseases 0.000 abstract 1
- 208000004756 Respiratory Insufficiency Diseases 0.000 abstract 1
- 206010038678 Respiratory depression Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 229940127240 opiate Drugs 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 230000000294 tussive effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Dental Preparations (AREA)
- Fats And Perfumes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75592391A | 1991-09-06 | 1991-09-06 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69215316D1 true DE69215316D1 (de) | 1997-01-02 |
| DE69215316T2 DE69215316T2 (de) | 1997-03-20 |
Family
ID=25041253
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69215316T Expired - Lifetime DE69215316T2 (de) | 1991-09-06 | 1992-09-04 | Zusammensetzungen, die Tramadol und irgendein Kodein, Oxykoden oder Hydrokoden enthalten, und deren Verwendung |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US5468744A (de) |
| EP (1) | EP0534628B1 (de) |
| JP (1) | JP3244540B2 (de) |
| KR (1) | KR100236666B1 (de) |
| CN (1) | CN1051705C (de) |
| AT (1) | ATE145330T1 (de) |
| AU (1) | AU657351B2 (de) |
| CA (1) | CA2077637C (de) |
| DE (1) | DE69215316T2 (de) |
| DK (1) | DK0534628T3 (de) |
| ES (1) | ES2096726T3 (de) |
| GR (1) | GR3022515T3 (de) |
| HU (1) | HU217584B (de) |
| IL (1) | IL103070A (de) |
| MX (1) | MX9205106A (de) |
| MY (1) | MY110317A (de) |
| NO (1) | NO300197B1 (de) |
| NZ (1) | NZ244250A (de) |
| PH (1) | PH31112A (de) |
| TW (1) | TW271394B (de) |
| ZA (1) | ZA926732B (de) |
| ZW (1) | ZW14392A1 (de) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100243956B1 (ko) | 1991-09-06 | 2000-03-02 | 랄프 알. 팔로 | 트라마돌 물질 및 아세트아미노펜을 포함하는 통증 치료용 약제학적 조성물 |
| US5958459A (en) * | 1991-12-24 | 1999-09-28 | Purdue Pharma L.P. | Opioid formulations having extended controlled released |
| US5478577A (en) * | 1993-11-23 | 1995-12-26 | Euroceltique, S.A. | Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level |
| US5968551A (en) | 1991-12-24 | 1999-10-19 | Purdue Pharma L.P. | Orally administrable opioid formulations having extended duration of effect |
| IL109460A (en) | 1993-05-10 | 1998-03-10 | Euro Celtique Sa | Controlled release formulation comprising tramadol |
| US7740881B1 (en) | 1993-07-01 | 2010-06-22 | Purdue Pharma Lp | Method of treating humans with opioid formulations having extended controlled release |
| IL110014A (en) | 1993-07-01 | 1999-11-30 | Euro Celtique Sa | Solid controlled-release oral dosage forms of opioid analgesics |
| US5879705A (en) * | 1993-07-27 | 1999-03-09 | Euro-Celtique S.A. | Sustained release compositions of morphine and a method of preparing pharmaceutical compositions |
| US5891471A (en) | 1993-11-23 | 1999-04-06 | Euro-Celtique, S.A. | Pharmaceutical multiparticulates |
| KR100354702B1 (ko) | 1993-11-23 | 2002-12-28 | 유로-셀티크 소시에떼 아노뉨 | 약학조성물의제조방법및서방형조성물 |
| US5843480A (en) | 1994-03-14 | 1998-12-01 | Euro-Celtique, S.A. | Controlled release diamorphine formulation |
| GB9422154D0 (en) | 1994-11-03 | 1994-12-21 | Euro Celtique Sa | Pharmaceutical compositions and method of producing the same |
| US5965161A (en) | 1994-11-04 | 1999-10-12 | Euro-Celtique, S.A. | Extruded multi-particulates |
| US6017963A (en) | 1995-11-14 | 2000-01-25 | Euro-Celtique, S.A. | Formulation for intranasal administration |
| GB9523566D0 (en) * | 1995-11-17 | 1996-01-17 | Euro Celtique Sa | Pharmaceutical formulation |
| DE19601744C2 (de) * | 1996-01-19 | 1998-04-16 | Gruenenthal Gmbh | Verfahren zur Herstellung der Enantiomeren von O-Demethyltramadol |
| DE19641576C1 (de) * | 1996-10-09 | 1998-05-07 | Gruenenthal Gmbh | Kombinationspräparat enthaltend Tramadol und einen Calcium-Kanal Antagonisten |
| DE19712398A1 (de) * | 1997-03-25 | 1998-10-01 | Gruenenthal Gmbh | Orale Anwendung von (+)-0-Demethyltramadol als Schmerzmittel |
| JP2001510180A (ja) | 1997-07-15 | 2001-07-31 | ラシンスキィ・リミテッド | トラマドール、その塩酸塩、及びそれらの製造方法 |
| US6156342A (en) * | 1998-05-26 | 2000-12-05 | Andex Pharmaceuticals, Inc. | Controlled release oral dosage form |
| US6608073B1 (en) | 1998-10-14 | 2003-08-19 | New Millennium Pharmaceutical Research, Inc. | Intranasal codeine for the rapid suppression of cough and rapid relief of pain |
| US6806294B2 (en) | 1998-10-15 | 2004-10-19 | Euro-Celtique S.A. | Opioid analgesic |
| DE19918325A1 (de) | 1999-04-22 | 2000-10-26 | Euro Celtique Sa | Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion |
| US20030118641A1 (en) * | 2000-07-27 | 2003-06-26 | Roxane Laboratories, Inc. | Abuse-resistant sustained-release opioid formulation |
| SK286621B6 (sk) | 1999-08-20 | 2009-02-05 | Ortho-Mcneil Pharmaceutical, Inc. | Farmaceutický prostriedok obsahujúci kombináciu tramadolového materiálu a antikonvulzívneho činidla, táto kombinácia a jej použitie na výrobu liečiva |
| DE19940740A1 (de) * | 1999-08-31 | 2001-03-01 | Gruenenthal Gmbh | Pharmazeutische Salze |
| PE20010623A1 (es) | 1999-10-05 | 2001-07-07 | Gruenenthal Chemie | Uso de (+)-tramadol y/o o-demetiltramadol para tratamiento de urgencia urinaria incrementada y/o incontinencia urinaria |
| KR20020059653A (ko) | 1999-10-29 | 2002-07-13 | 그린 마틴, 브라이언 쥐 테슬리 | 서방성 하이드로코돈 제형 |
| US10179130B2 (en) | 1999-10-29 | 2019-01-15 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
| US6297286B1 (en) * | 1999-11-09 | 2001-10-02 | Darwin Discovery, Ltd. | Therapeutic use and formulation |
| HU230686B1 (en) | 2000-10-30 | 2017-08-28 | Euro Celtique Sa | Controlled release hydrocodone compositions |
| WO2002074241A2 (en) * | 2001-03-16 | 2002-09-26 | Dmi Biosciences Inc. | Method of delaying ejaculation |
| US20110104214A1 (en) | 2004-04-15 | 2011-05-05 | Purdue Pharma L.P. | Once-a-day oxycodone formulations |
| UA81224C2 (uk) | 2001-05-02 | 2007-12-25 | Euro Celtic S A | Дозована форма оксикодону та її застосування |
| WO2003048113A1 (en) | 2001-11-30 | 2003-06-12 | Sepracor Inc. | Tramadol analogs and uses thereof |
| EP1364649A1 (de) * | 2002-05-23 | 2003-11-26 | Cilag AG | Topirimat-Tramadol Addukt und seine Verwendung |
| US20040058946A1 (en) * | 2002-07-05 | 2004-03-25 | Buchwald Stephen L. | Abuse-resistant prodrugs of oxycodone and other pharmaceuticals |
| PL377351A1 (pl) * | 2002-12-13 | 2006-01-23 | Cilag Ag | Preparaty o kontrolowanym uwalnianiu zawierające tramadol i topiramat |
| WO2007104108A1 (en) * | 2006-03-15 | 2007-09-20 | Graydon,, Cameron | Non-codeine opioid analgesic process and formulations |
| MX2010005680A (es) * | 2007-11-23 | 2010-12-21 | Protect Pharmaceutical Corp | Composiciones de tapentadol. |
| US20090264454A1 (en) * | 2008-04-16 | 2009-10-22 | Nickell Robert P | Combined hydrocodone and analgesic formulation and method |
| US20100003322A1 (en) * | 2008-07-03 | 2010-01-07 | Lai Felix S | Enteric coated hydrophobic matrix formulation |
| US20100190752A1 (en) | 2008-09-05 | 2010-07-29 | Gruenenthal Gmbh | Pharmaceutical Combination |
| US10702485B2 (en) | 2011-07-09 | 2020-07-07 | Syntrix Biosystems Inc. | Compositions and methods for overcoming resistance to tramadol |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3652589A (en) * | 1967-07-27 | 1972-03-28 | Gruenenthal Chemie | 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols |
| WO1993002707A1 (de) * | 1991-08-06 | 1993-02-18 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Neue antidiarrhoica |
| AU2062892A (en) * | 1991-08-16 | 1993-02-18 | Mcneil-Ppc, Inc. | Potentiation of antitussive effect of dextromethorphan |
-
1992
- 1992-09-04 CA CA002077637A patent/CA2077637C/en not_active Expired - Lifetime
- 1992-09-04 MX MX9205106A patent/MX9205106A/es unknown
- 1992-09-04 HU HU9202845A patent/HU217584B/hu unknown
- 1992-09-04 DK DK92308076.6T patent/DK0534628T3/da active
- 1992-09-04 ZA ZA926732A patent/ZA926732B/xx unknown
- 1992-09-04 NO NO923453A patent/NO300197B1/no not_active IP Right Cessation
- 1992-09-04 DE DE69215316T patent/DE69215316T2/de not_active Expired - Lifetime
- 1992-09-04 ZW ZW14392A patent/ZW14392A1/xx unknown
- 1992-09-04 ES ES92308076T patent/ES2096726T3/es not_active Expired - Lifetime
- 1992-09-04 AU AU22185/92A patent/AU657351B2/en not_active Expired
- 1992-09-04 EP EP92308076A patent/EP0534628B1/de not_active Expired - Lifetime
- 1992-09-04 MY MYPI92001591A patent/MY110317A/en unknown
- 1992-09-04 PH PH44893A patent/PH31112A/en unknown
- 1992-09-04 AT AT92308076T patent/ATE145330T1/de active
- 1992-09-05 CN CN92111382A patent/CN1051705C/zh not_active Expired - Lifetime
- 1992-09-05 KR KR1019920016227A patent/KR100236666B1/ko not_active IP Right Cessation
- 1992-09-06 IL IL10307092A patent/IL103070A/en not_active IP Right Cessation
- 1992-09-07 NZ NZ244250A patent/NZ244250A/en not_active IP Right Cessation
- 1992-09-07 JP JP26269392A patent/JP3244540B2/ja not_active Expired - Lifetime
- 1992-11-10 TW TW081108967A patent/TW271394B/zh not_active IP Right Cessation
-
1994
- 1994-06-30 US US08/268,382 patent/US5468744A/en not_active Expired - Lifetime
-
1997
- 1997-02-12 GR GR960403334T patent/GR3022515T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE145330T1 (de) | 1996-12-15 |
| DK0534628T3 (da) | 1996-12-09 |
| MY110317A (en) | 1998-04-30 |
| US5468744A (en) | 1995-11-21 |
| IL103070A (en) | 1996-10-16 |
| CN1051705C (zh) | 2000-04-26 |
| HU9202845D0 (en) | 1992-11-30 |
| MX9205106A (es) | 1993-05-01 |
| ES2096726T3 (es) | 1997-03-16 |
| NO923453D0 (no) | 1992-09-04 |
| DE69215316T2 (de) | 1997-03-20 |
| TW271394B (de) | 1996-03-01 |
| ZW14392A1 (en) | 1994-05-11 |
| JP3244540B2 (ja) | 2002-01-07 |
| AU2218592A (en) | 1993-03-11 |
| NO300197B1 (no) | 1997-04-28 |
| CA2077637C (en) | 2007-01-09 |
| KR100236666B1 (ko) | 2000-03-02 |
| CA2077637A1 (en) | 1993-03-07 |
| EP0534628B1 (de) | 1996-11-20 |
| HU217584B (hu) | 2000-02-28 |
| CN1071835A (zh) | 1993-05-12 |
| AU657351B2 (en) | 1995-03-09 |
| HUT63556A (en) | 1993-09-28 |
| NO923453L (no) | 1993-03-08 |
| KR930005617A (ko) | 1993-04-20 |
| NZ244250A (en) | 1994-01-26 |
| IL103070A0 (en) | 1993-02-21 |
| ZA926732B (en) | 1994-03-04 |
| EP0534628A1 (de) | 1993-03-31 |
| PH31112A (en) | 1998-02-23 |
| GR3022515T3 (en) | 1997-05-31 |
| JPH06107540A (ja) | 1994-04-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69215316T2 (de) | Zusammensetzungen, die Tramadol und irgendein Kodein, Oxykoden oder Hydrokoden enthalten, und deren Verwendung | |
| EP0566709A4 (de) | ||
| IL103594A0 (en) | Compositions comprising a tramadol material and a nonsteroidal anti-inflammatory drug | |
| DE69207526T2 (de) | Tramadol N-Oxid, dessen Enantiomere und Zusammensetzungen davon, und deren Verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8328 | Change in the person/name/address of the agent |
Representative=s name: BOEHMERT & BOEHMERT, 28209 BREMEN |
|
| R071 | Expiry of right |
Ref document number: 534628 Country of ref document: EP |